Home / Without Label / CLLS Cellectis S.A. gains 51% Dec 10, 2020

Thursday, December 10, 2020

CLLS Cellectis S.A. gains 51% Dec 10, 2020

priceSeries Thursday, December 10, 2020 0 Comment

Developing cancer immunotherapies based on gene-edited CAR T-cells.http://www.priceseries.com/trade/CLLS-Cellectis-SA-stock-gains-51-percent-a-Trade-Record-by-priceSeries-2020111120201210.html

Posted by : priceSeries Thursday, December 10, 2020

No Comments

Subscribe to: Post Comments (Atom)